Medical News

RSS

Ambit Biosciences and Astellas Pharma to jointly develop and commercialize FLT3 kinase inhibitors

Ambit Biosciences Corporation and Astellas Pharma Inc. today announced that they have entered into a worldwide agreement to jointly develop and commercialize FLT3 kinase inhibitors in oncology and non-oncology indications.

18 Dec 2009

ELH offers vision product line for North Carolina and Tennessee employers

Eastern Life & Health Insurance Company (ELH), a subsidiary of Eastern Insurance Holdings, Inc. (Nasdaq: EIHI), announced today that its vision product line will now be available to North Carolina and Tennessee employers.

18 Dec 2009

Practice Fusion continues to be the fastest growing EHR community in the US

Practice Fusion today announced that the company's user base has grown 400% in 2009 to surpass 25,000 medical professionals. Practice Fusion continues to be the fastest growing Electronic Health Record (EHR) community in the US, serving the needs of family practice and private practice physicians across the country.

18 Dec 2009

BDI Pharma introduces SecuriVAX for online ordering of vaccines

BDI Pharma, Inc. (BDI), the fastest growing national distributor of biotech therapies, announced today the introduction of SecuriVAX(SM) (www.securivax.com), an online supply solution providing the healthcare community a one-stop source for a wide variety of vaccines.

18 Dec 2009

Ambulatory monitoring technique can disturb sleep and raise nighttime blood pressure

A widely used test for measuring nighttime blood pressure may interfere with patients' sleep, thus affecting the results of the test, reports a study in an upcoming issue of Clinical Journal of the American Society of Nephrology (CJASN).

18 Dec 2009

Four commonly used chemotherapy drugs disrupt birth of new brain cells, shows study

Researchers have developed a novel animal model showing that four commonly used chemotherapy drugs disrupt the birth of new brain cells, and that the condition could be partially reversed with the growth factor IGF-1.

18 Dec 2009

New study to examine physical activity and dietary behavior of colorectal cancer patients

In an effort to build the groundwork for future research on health promotion among individuals with colorectal and other cancers, a team of investigators at The Cancer Institute of New Jersey (CINJ) has launched a new study examining patterns in physical activity and eating habits of colorectal cancer patients who have recently finished treatment. CINJ is a Center of Excellence of UMDNJ-Robert Wood Johnson Medical School.

18 Dec 2009

AANS and CNS oppose Senate healthcare reform

The American Association of Neurological Surgeons (AANS) and Congress of Neurological Surgeons (CNS) have joined thousands of other physicians from 12 medical specialty organizations to deliver an urgent message to the public and to Congress: we need reform, but this isn’t the right reform; urge your Senator to vote “NO” on the Patient Protection and Affordable Care Act (H.R. 3590) as introduced by Senate Majority Leader Harry Reid.

18 Dec 2009

Unigene Laboratories selects UGP281 lead peptide from obesity program for development

Unigene Laboratories, Inc. (http://www.unigene.com) announced today that it has selected a lead peptide compound, designated UGP281, from its obesity program for development.

18 Dec 2009

AST: Finding right autism treatment can greatly impact child's progress and future quality of life

Autism Spectrum Therapies (AST), an agency providing behavior therapy and other autism services throughout Southern California, offers practical tips for parents on selecting the best autism service provider for their child.

18 Dec 2009

Victhom Human Bionics signs new license agreement with Ossur

Victhom Human Bionics Inc. ("Victhom", TSX: VHB) announced today that it had entered into a new license agreement to replace previous collaboration agreement with partner Ossur and sold certain Biotronix assets to Ossur for a total consideration of USD 500,000.

18 Dec 2009

Genetic variant associated with reduced risk of COPD

What: Researchers have discovered evidence that suggests a genetic variant may be associated with better preserved lung function among children with asthma and adults who smoke, according to a new study funded by the National Heart, Lung, and Blood Institute (NHLBI), which is part of the National Institutes of Health.

18 Dec 2009

Access to convenience stores can pormote childhood obesity

Childhood obesity is directly related to how close kids live to convenience stores, according to the preliminary findings of a major Canadian study presented at the Entretiens Jacques-Cartier in Lyon, France. The ongoing study is named QUALITY for Quebec Adipose and Lifestyle InvesTigation in Youth.

18 Dec 2009

RADeCO Health launches RADView CT dosimeter

Just how much exposure to radiation from CT scans is too much and how do those working with patients in the CT scan environment and their patients protect themselves from over exposure? Veteran-owned RADeCO Health, Inc. of Sandwich, Ma. (www.radecohealth.com) today announced the launch of the RADView(TM) CT dosimeter, a new monitoring device designed to monitor ionizing radiation exposures from Computed Tomography (CT) scans of patients.

18 Dec 2009

Flu-fighting proteins found in human cells stop flu virus, uncover scientists

In findings that may lead to better ways to prevent and treat influenza and other viral infections, researchers report the discovery of a family of naturally occurring antiviral agents in human cells.

18 Dec 2009

Antidepressants may play a key role in improving adolescents’ mental health

Suicidal adolescents who were prescribed an antidepressant medication during inpatient psychiatric hospital treatment were 85 percent less likely than others to be readmitted within a month after discharge, a new study found.

18 Dec 2009

Regulus Therapeutics wins exclusive rights to modulate microRNAs

Regulus Therapeutics Inc., founded by Alnylam Pharmaceuticals, Inc. and Isis Pharmaceuticals, Inc., announced today that it has obtained exclusive rights from the California Institute of Technology to inventions made in the laboratory of David Baltimore, Ph.D. covering methods and compositions for modulating microRNA-146 and microRNA-155.

18 Dec 2009

Neurogen receives listing compliance notice letter from NASDAQ

Neurogen Corporation announced today that it received a NASDAQ staff determination letter on December 11, 2009, notifying the company that it has not regained compliance, during a prescribed period, with NASDAQ Listing Rule 5450(a)(1), which requires the stock of listed companies to trade at or above $1.00 per share.

18 Dec 2009

Attitudes of overweight and normal weight adults regarding exercise at health clubs

Time and time again, it has been documented that regular exercise has many health benefits including lowering risks associated with the comorbidities of obesity.

18 Dec 2009

Sepracor's LUNESTA receives patent term extension from USPTO

Sepracor Inc. today announced that the United States Patent and Trademark Office has determined that U.S. Patent No. 6,444,673, which is a composition of matter patent that covers the human drug product LUNESTA® (eszopiclone), received a patent term extension under 35 U.S.C. § 156.

18 Dec 2009